reference/428487

Predicate	Object
contentType	Journal Article
endingPage	112
issn	1178-1661 1178-1653
issueIdentifier	2
pageRange	105-112
publicationName	The Patient - Patient-Centered Outcomes Research
startingPage	105
bibliographicCitation	Kamat SA, Rajagopalan K, Stephenson JJ, Agarwal S. Impact of natalizumab on patient-reported outcomes in a clinical practice setting: a cross-sectional survey. Patient. 2009 Jun 01;2(2):105–12. doi: 10.2165/01312067-200902020-00006. PMID: 22273086.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_49b11465e6db02319101dc5b718ef768 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_499eee4b8b88197198ba0080505b712f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d9d024c17d27c5888a3dcd01ddf85af http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fdef14eab1c63df6746c681aaa0ca37c
date	2009-06-01^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/22273086 https://doi.org/10.2165/01312067-200902020-00006
isPartOf	https://portal.issn.org/resource/ISSN/1178-1653 https://portal.issn.org/resource/ISSN/1178-1661 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/36646
language	English
source	https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Impact of natalizumab on patient-reported outcomes in a clinical practice setting: a cross-sectional survey

Showing number of triples: 1 to 24 of 24.